Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects

Modulated electrohyperthermia (mEHT), an innovative complementary technique of radio-, chemo-, and targeted oncotherapy modalities, can induce tumor apoptosis and contribute to a secondary immune-mediated cancer death. Here, we tested the efficiency of high-fever range (~42 °C) mEHT on B16F...

Full description

Bibliographic Details
Main Authors: Balázs Besztercei, Tamás Vancsik, Anett Benedek, Enikő Major, Mbuotidem J. Thomas, Csaba A. Schvarcz, Tibor Krenács, Zoltán Benyó, Andrea Balogh
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/16/4019
id doaj-3397b0d9070c489fa15ab18e42b1ebf5
record_format Article
spelling doaj-3397b0d9070c489fa15ab18e42b1ebf52020-11-25T00:28:00ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-08-012016401910.3390/ijms20164019ijms20164019Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic EffectsBalázs Besztercei0Tamás Vancsik1Anett Benedek2Enikő Major3Mbuotidem J. Thomas4Csaba A. Schvarcz5Tibor Krenács6Zoltán Benyó7Andrea Balogh8Institute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, Hungary1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1097 Budapest, HungaryInstitute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, HungaryInstitute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, HungaryInstitute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, HungaryInstitute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, Hungary1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1097 Budapest, HungaryInstitute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, HungaryInstitute of Clinical Experimental Research, Semmelweis University, 1097 Budapest, HungaryModulated electrohyperthermia (mEHT), an innovative complementary technique of radio-, chemo-, and targeted oncotherapy modalities, can induce tumor apoptosis and contribute to a secondary immune-mediated cancer death. Here, we tested the efficiency of high-fever range (~42 &#176;C) mEHT on B16F10 melanoma both in cell culture and allograft models. In vivo, mEHT treatment resulted in significant tumor size reduction when repeated three times, and induced major stress response as indicated by upregulated cytoplasmic and cell membrane hsp70 levels. Despite the increased PUMA and apoptosis-inducing factor 1, and moderate rise in activated-caspase-3, apoptosis was not significant. However, phospho-H2AX indicated DNA double-strand breaks, which upregulated p53 protein and its downstream cyclin-dependent kinase inhibitors p21<sup>waf1</sup> and p27<sup>kip</sup>. Combined in vitro treatment with mEHT and the p53 activator nutlin-3a additively reduced cell viability compared to monotherapies. Though mEHT promoted the release of damage-associated molecular pattern (DAMP) damage signaling molecules hsp70, HMGB1 and ATP to potentiate the tumor immunogenicity of melanoma allografts, it reduced MHC-I and melan-A levels in tumor cells. This might explain why the number of cytotoxic T cells was moderately reduced, while the amount of natural killer (NK) cells was mainly unchanged and only macrophages increased significantly. Our results suggest that mEHT-treatment-related tumor growth control was primarily mediated by cell-stress-induced p53, which upregulated cyclin-dependent kinase inhibitors. The downregulated tumor antigen-presenting machinery may explain the reduced cytotoxic T-cell response despite increased DAMP signaling. Decreased tumor antigen and MHC-I levels suggest that natural killer (NK) cells and macrophages were the major contributors to tumor eradication.https://www.mdpi.com/1422-0067/20/16/4019electrohyperthermiamelanomastress responsetumor growth arresthsp70MHC-I
collection DOAJ
language English
format Article
sources DOAJ
author Balázs Besztercei
Tamás Vancsik
Anett Benedek
Enikő Major
Mbuotidem J. Thomas
Csaba A. Schvarcz
Tibor Krenács
Zoltán Benyó
Andrea Balogh
spellingShingle Balázs Besztercei
Tamás Vancsik
Anett Benedek
Enikő Major
Mbuotidem J. Thomas
Csaba A. Schvarcz
Tibor Krenács
Zoltán Benyó
Andrea Balogh
Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
International Journal of Molecular Sciences
electrohyperthermia
melanoma
stress response
tumor growth arrest
hsp70
MHC-I
author_facet Balázs Besztercei
Tamás Vancsik
Anett Benedek
Enikő Major
Mbuotidem J. Thomas
Csaba A. Schvarcz
Tibor Krenács
Zoltán Benyó
Andrea Balogh
author_sort Balázs Besztercei
title Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
title_short Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
title_full Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
title_fullStr Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
title_full_unstemmed Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
title_sort stress-induced, p53-mediated tumor growth inhibition of melanoma by modulated electrohyperthermia in mouse models without major immunogenic effects
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-08-01
description Modulated electrohyperthermia (mEHT), an innovative complementary technique of radio-, chemo-, and targeted oncotherapy modalities, can induce tumor apoptosis and contribute to a secondary immune-mediated cancer death. Here, we tested the efficiency of high-fever range (~42 &#176;C) mEHT on B16F10 melanoma both in cell culture and allograft models. In vivo, mEHT treatment resulted in significant tumor size reduction when repeated three times, and induced major stress response as indicated by upregulated cytoplasmic and cell membrane hsp70 levels. Despite the increased PUMA and apoptosis-inducing factor 1, and moderate rise in activated-caspase-3, apoptosis was not significant. However, phospho-H2AX indicated DNA double-strand breaks, which upregulated p53 protein and its downstream cyclin-dependent kinase inhibitors p21<sup>waf1</sup> and p27<sup>kip</sup>. Combined in vitro treatment with mEHT and the p53 activator nutlin-3a additively reduced cell viability compared to monotherapies. Though mEHT promoted the release of damage-associated molecular pattern (DAMP) damage signaling molecules hsp70, HMGB1 and ATP to potentiate the tumor immunogenicity of melanoma allografts, it reduced MHC-I and melan-A levels in tumor cells. This might explain why the number of cytotoxic T cells was moderately reduced, while the amount of natural killer (NK) cells was mainly unchanged and only macrophages increased significantly. Our results suggest that mEHT-treatment-related tumor growth control was primarily mediated by cell-stress-induced p53, which upregulated cyclin-dependent kinase inhibitors. The downregulated tumor antigen-presenting machinery may explain the reduced cytotoxic T-cell response despite increased DAMP signaling. Decreased tumor antigen and MHC-I levels suggest that natural killer (NK) cells and macrophages were the major contributors to tumor eradication.
topic electrohyperthermia
melanoma
stress response
tumor growth arrest
hsp70
MHC-I
url https://www.mdpi.com/1422-0067/20/16/4019
work_keys_str_mv AT balazsbesztercei stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT tamasvancsik stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT anettbenedek stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT enikomajor stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT mbuotidemjthomas stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT csabaaschvarcz stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT tiborkrenacs stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT zoltanbenyo stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
AT andreabalogh stressinducedp53mediatedtumorgrowthinhibitionofmelanomabymodulatedelectrohyperthermiainmousemodelswithoutmajorimmunogeniceffects
_version_ 1725337367587323904